EMA’s human medicines committee recommends approval of GSK’s single-vial, fully liquid presentation of Menveo meningococcal vaccine: London, UK Wednesday, September 25, 2024, ...

GSK plc (GSK, GSK.L) announced the European Medicine Agency's Committee for Medicinal Products for Human Use or CHMP has recommended ...

Pharmaceutical and biotechnology company GSK said on Tuesday that the European Medicine Agency has recommended meningococcal ...

GSK) has big plans for its future, as it is aiming for GBP38 billion in sales in 2031. Focusing on the present, three of the firm’s top selling products are Menveo and Bexsero which are ...

with a safety profile consistent with Bexsero and Menveo. GSK’s chief scientific officer, Tony Wood, said that the results show the vaccine protects against “the broadest panel of circulating ...

The new vaccine is a combination of GSK’s already-approved vaccines Bexsero and Menveo and is designed to protect against meningitis and blood poisoning caused by the A, B, C, W, and Y ...

(Alliance News) - GSK PLC on Tuesday announced a new positive opinion from the EU's European Medicine Agency's Committee for Medicinal Products for Human Use. The London-based pharmaceutical company ...

Building materials supplier CRH has appointed Chief Financial Officer Jim Mintern, a board director since June 2021, as its new chief executive officer. He succeeds Albert Manifold, who plans to ...

The European stock markets closed higher in Tuesday trading as the Stoxx Europe 600 rose 0.58%, the Swiss Market Index climbed 0.70%, France's CAC increased 1.28%, the FTSE in London gained 0.28%, and ...

GSK) has big plans for its future, as it is aiming for GBP38 billion in sales in 2031. Focusing on the present, three of the firm’s top selling products are Menveo and Bexsero which are ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on GlaxoSmithKline (GB:GSK – Research Report), Sonova Holding AG (CH:SOON – Research Report) and Corbus Pharmaceuticals ...

GSK has demonstrated robust sales growth, with a 13% increase to GBP 7.9 billion and a core operating profit up by 21% to GBP 2.5 billion, as noted by CEO Emma Walmsley in the latest earnings call.